Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Director departure

Cara Therapeutics, Inc. (CARA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Investor presentation
Docs: "Corporate Presentation August 2023"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2023 Financial Results"
08/04/2023 4 Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 4,307 shares @ $3.07, valued at $13.2k
08/04/2023 4 Boudreau Helen M (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Granted 155,747 options to buy @ $3.09, valued at $481.3k
08/04/2023 3 Boudreau Helen M (Director) has filed a Form 3 on Cara Therapeutics, Inc.
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors"
07/25/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/07/2023 SC 13G/A BlackRock Inc. reports a 6.9% stake in CARA THERAPEUTICS INC
05/09/2023 4 Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 3,869 shares @ $4.4, valued at $17k
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/23/2023 8-K Investor presentation
Docs: "Corporate Presentation March 2023"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/07/2023 4 Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 5,987 shares @ $9.71, valued at $58.1k
03/07/2023 4 Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 6,802 shares @ $9.71, valued at $66k
03/07/2023 4 Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 6,256 shares @ $9.71, valued at $60.7k
03/07/2023 4 Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 6,221 shares @ $9.71, valued at $60.4k
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
Docs: "Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results"
02/03/2023 4 Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 4,191 shares @ $11.8, valued at $49.5k
01/20/2023 SC 13G/A BlackRock Inc. reports a 14.4% stake in CARA THERAPEUTICS INC
01/19/2023 4 von Moltke Lisa (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Granted 45,841 options to buy @ $10.74, valued at $492.3k
01/19/2023 4 Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 2,265 shares @ $10.81, valued at $24.5k
01/09/2023 8-K Investor presentation
Docs: "Corporate Presentation"
01/03/2023 4 Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 2,265 shares @ $10.18, valued at $23.1k
12/23/2022 4 Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 3,506 shares @ $11.27, valued at $39.5k
12/23/2022 4 Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 2,992 shares @ $11.27, valued at $33.7k
12/23/2022 4 Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Sold 2,561 shares @ $11.27, valued at $28.9k
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy